Liminatus Pharma and Iris Acquisition Corp Announce Completion of Business Combination - IssueWire

Send Email To PR Contact - PR 1830846231386402

To : PR Contact Email ( *****@arrcap.com )

Your Email

Your Name

Message

Issuewire

MAIL FOR NEWSLETTER

IssueWire Magazine

Have any questions?
info@issuewire.com

IssueWire Magazine

Copyright © 2025 IssueWire.